Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 81581722 | 8158172 | 2 | F | 201109 | 20121022 | 20110927 | 20121029 | EXP | PHHY2011MX82367 | NOVARTIS | 76.00 | YR | F | Y | 0.00000 | 20121029 | CN | MX | MX |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 81581722 | 8158172 | 1 | PS | CO-DIOVAN | 1 | ORAL | 2 DF (80MG VALS, 12,5 MG HYDROCH) DAILY | U | 20818 | 2 | DF | Film-Coated Tablet | |||||||
| 81581722 | 8158172 | 2 | SS | CO-DIOVAN | 1 | ORAL | 2 DF (160MG VALS, 12,5 MG HYDRO) DAILY | U | 20818 | 2 | DF | Film-Coated Tablet |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 81581722 | 8158172 | 1 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 81581722 | 8158172 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 81581722 | 8158172 | Mental disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 81581722 | 8158172 | 1 | 200910 | 0 |